Administration of Atosiban, an oxytocin receptor antagonist, ameliorates autistic-like behaviors in a female rat model of valproic acid-induced autism
Behavioural Brain Research · 2024
DOI: 10.1016/j.bbr.2024.115052 ↗Kurz gefasst
Fachartikel in der Zeitschrift Behavioural Brain Research, 2024. Verfasst von Chunhua Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Nankai University, Tianjin 300071, PR China. Hauptthemen laut MEDLINE: Valproic Acid, Receptors, Oxytocin, Disease Models, Animal, Oxytocin. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 70 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Autism spectrum disorder (ASD) is a pervasive developmental disorder with gender differences. Oxytocin (OXT) is currently an important candidate drug for autism, but the lack of data on female autism is a big issue. It has been reported that the effect of OXT is likely to be different between male and female ASD patients. In the study, we specifically explored the role of the OXT signaling pathway in a VPA-induced female rat's model of autism. The data showed that there was an increase of either oxytocin or its receptor expressions in both the hippocampus and the prefrontal cortex of VPA-induced female offspring. To determine if the excess of OXT signaling contributed to autism symptoms in female rats, exogenous oxytocin and oxytocin receptor antagonists Atosiban were used in the experiment. It was found that exogenous oxytocin triggered autism-like behaviors in wild-type female rats by intranasal administration. More interestingly, several autism-like deficits including social interaction, anxiety, and repeat stereotypical sexual behavior in the VPA female offspring were significantly attenuated by oxytocin receptor antagonists Atosiban. Moreover, Atosiban also effectively improved the synaptic plasticity impairment induced by VPA in female offspring. Our results suggest that oxytocin receptor antagonists significantly improve autistic-like behaviors in a female rat model of valproic acid-induced autism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, Nankai University, Tianjin 300071, PR China.
- College of Life Sciences and Key Laboratory of Bioactive Materials Ministry of Education, Nankai University, Tianjin 300071, PR China.
- Graduate School of Engineering, Saitama Institute of Technology, Fukaya 369-0217, Japan.
- College of Life Sciences and Key Laboratory of Bioactive Materials Ministry of Education, Nankai University, Tianjin 300071, PR China. Electronic address: zhangtao@nankai.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Liu, C., Guo, Z., Pang, J., Zhang, Y., Yang, Z., Cao, J., & Zhang, T. (2024). Administration of Atosiban, an oxytocin receptor antagonist, ameliorates autistic-like behaviors in a female rat model of valproic acid-induced autism. Behavioural Brain Research. https://doi.org/10.1016/j.bbr.2024.115052
Vancouver
Liu C, Guo Z, Pang J, Zhang Y, Yang Z, Cao J, et al. Administration of Atosiban, an oxytocin receptor antagonist, ameliorates autistic-like behaviors in a female rat model of valproic acid-induced autism. Behavioural Brain Research. 2024. doi:10.1016/j.bbr.2024.115052
BibTeX
@article{Liu2024,
author = {Liu, Chunhua and Guo, Zhengyang and Pang, Jiyi and Zhang, Yuying and Yang, Zhuo and Cao, Jianting and Zhang, Tao},
title = {Administration of Atosiban, an oxytocin receptor antagonist, ameliorates autistic-like behaviors in a female rat model of valproic acid-induced autism},
journal = {Behavioural Brain Research},
year = {2024},
doi = {10.1016/j.bbr.2024.115052}
}
EUVIMED